Related references
Note: Only part of the references are listed.Apatinib and Ginsenoside-Rb1 Synergetically Control the Growth of Hypopharyngeal Carcinoma Cells
YanWei Li et al.
DISEASE MARKERS (2022)
AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistance in multiple myeloma
Chunyan Gu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)
Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways
Lukas Kraehenbuehl et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2022)
Korean Red Ginseng Enhances Immunotherapeutic Effects of NK Cells via Eosinophils in Metastatic Liver Cancer Model
Hee Jung Kwon et al.
NUTRIENTS (2022)
Upregulation of adiponectin by Ginsenoside Rb1 contributes to amelioration of hepatic steatosis induced by high fat diet
Yaru Li et al.
JOURNAL OF GINSENG RESEARCH (2022)
Versatile ginsenoside Rg3 liposomes inhibit tumor metastasis by capturing circulating tumor cells and destroying metastatic niches
Jiaxuan Xia et al.
SCIENCE ADVANCES (2022)
Case Report: Benefits of a NSCLC Patient With EGFR A289G/F287_G288insHA cis Mutations From Immunotherapy in Combination With Antiangiogenesis and Chemotherapy and Sequential Treatment of EGFR-TKI
He Zhang et al.
FRONTIERS IN ONCOLOGY (2022)
The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancer
Hai Wang et al.
CELL METABOLISM (2022)
First-line chemotherapy plus immune checkpoint inhibitors or bevacizumab in advanced non-squamous non-small-cell lung cancer without EGFR mutations or ALK fusions
Panpan Jiang et al.
IMMUNOTHERAPY (2022)
Oxidative Stress and Ginsenosides: An Update on the Molecular Mechanisms
Bo He et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2022)
The roles of TGF-I3 and VEGF pathways in the suppression of antitumor immunity in melanoma and other solid tumors
Melissa T. Bu et al.
PHARMACOLOGY & THERAPEUTICS (2022)
Ginsenoside Rg3 ameliorates myocardial glucose metabolism and insulin resistance via activating the AMPK signaling pathway
Jingyu Ni et al.
JOURNAL OF GINSENG RESEARCH (2022)
Ginsenoside Rg1 attenuates cerebral ischemia-reperfusion injury due to inhibition of NOX2-mediated calcium homeostasis dysregulation in mice
Yuli Han et al.
JOURNAL OF GINSENG RESEARCH (2022)
Ginseng: A bibliometric analysis of 40-year journey of global clinical trials
Weijie Chen et al.
JOURNAL OF ADVANCED RESEARCH (2021)
Ginsenoside Rg1 prevents bone marrow mesenchymal stem cell senescence via NRF2 and PI3K/Akt signaling
Ziling Wang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2021)
Ginsenosides in Panax genus and their biosynthesis
Maoqi Hou et al.
ACTA PHARMACEUTICA SINICA B (2021)
Antioxidant and Anti-Inflammatory Effects of Korean Black Ginseng Extract through ER Stress Pathway
Mi-Yeong An et al.
ANTIOXIDANTS (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Ginsenosides emerging as both bifunctional drugs and nanocarriers for enhanced antitumor therapies
Hong Wang et al.
JOURNAL OF NANOBIOTECHNOLOGY (2021)
Multiplexed single-cell analysis of organoid signaling networks
Jahangir Sufi et al.
NATURE PROTOCOLS (2021)
Inhibition of STAT3/PD-L1 and Activation of miR193a-5p Are Critically Involved in Apoptotic Effect of Compound K in Prostate Cancer Cells
Jae-Hee Lee et al.
CELLS (2021)
Atractylenolide I enhances responsiveness to immune checkpoint blockade therapy by activating tumor antigen presentation
Hanchen Xu et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Ginsenoside-Rg3 inhibits the proliferation and invasion of hepatoma carcinoma cells via regulating long non-coding RNA HOX antisense intergenic
Zhongjian Pu et al.
BIOENGINEERED (2021)
Ginseng berry polysaccharides on inflammation-associated colon cancer: inhibiting T-cell differentiation, promoting apoptosis, and enhancing the effects of 5-fluorouracil
Chong-Zhi Wang et al.
JOURNAL OF GINSENG RESEARCH (2020)
Ginsenoside Rg5 overcomes chemotherapeutic multidrug resistance mediated by ABCB1 transporter: in vitro and in vivo study
Sen-Ling Feng et al.
JOURNAL OF GINSENG RESEARCH (2020)
Genome-scale CRISPR screening for potential targets of ginsenoside compound K
Yuanyuan Yang et al.
CELL DEATH & DISEASE (2020)
Ginsenoside Rh4 suppresses aerobic glycolysis and the expression of PD-L1 via targeting AKT in esophageal cancer
Xuqian Deng et al.
BIOCHEMICAL PHARMACOLOGY (2020)
Targeting CD133 reverses drug-resistance via the AKT/NF-κB/MDR1 pathway in colorectal cancer
Zeting Yuan et al.
BRITISH JOURNAL OF CANCER (2020)
Korean red ginseng for cancer-related fatigue in colorectal cancer patients with chemotherapy: A randomised phase III trial ocr
Jin Won Kim et al.
EUROPEAN JOURNAL OF CANCER (2020)
Ginsenoside F2 attenuates chronic-binge ethanol-induced liver injury by increasing regulatory T cells and decreasing Th17 cells
Myung-Ho Kim et al.
JOURNAL OF GINSENG RESEARCH (2020)
Single-cell RNA sequencing in cardiovascular development, disease and medicine
David T. Paik et al.
NATURE REVIEWS CARDIOLOGY (2020)
Ginsenoside panaxatriol reverses TNBC paclitaxel resistance by inhibiting the IRAK1/NF-κB and ERK pathways
Panpan Wang et al.
PEERJ (2020)
Targeting STAT3 in Cancer Immunotherapy
Sailan Zou et al.
MOLECULAR CANCER (2020)
Ginsenoside Rh3 Inhibits Proliferation and Induces Apoptosis of Colorectal Cancer Cells
Zhongyi Cong et al.
PHARMACOLOGY (2020)
Ginsenoside Rk1 induces apoptosis and downregulates the expression of PD-L1 by targeting the NF-κB pathway in lung adenocarcinoma
Manling Hu et al.
FOOD & FUNCTION (2020)
Ginsenoside Rb1 can ameliorate the key inflammatory cytokines TNF-alpha and IL-6 in a cancer cachexia mouse model
Shuai Lu et al.
BMC COMPLEMENTARY MEDICINE AND THERAPIES (2020)
Effect of Korean Red Ginseng extract on colorectal lung metastasis through inhibiting the epithelial-mesenchymal transition via transforming growth factor-β1/Smad-signaling-mediated Snail/E-cadherin expression
Ji-Ye Kee et al.
JOURNAL OF GINSENG RESEARCH (2019)
Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivo
Albert A. De Vera et al.
CANCER LETTERS (2019)
Ginsenoside Rb2 inhibits epithelial-mesenchymal transition of colorectal cancer cells by suppressing TGF-β/Smad signaling
Dai Guoliang et al.
PHYTOMEDICINE (2019)
Progress of colorectal cancer screening in United States: Past achievements and future challenges
Eric M. Montminy et al.
PREVENTIVE MEDICINE (2019)
Ginsenoside Rk1 induces cell cycle arrest and apoptosis in MDA-MB-231 triple negative breast cancer cells
Yinan Hong et al.
TOXICOLOGY (2019)
Ginsenoside Rg3 improves cyclophosphamide-induced immunocompetence in Balb/c mice
Xiao Liu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
Ginsenoside Rh2 reverses cyclophosphamide-induced immune deficiency by regulating fatty acid metabolism
Ying Qian et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2019)
Ginsenoside F1 promotes angiogenesis by activating the IGF-1/IGF1R pathway
Jiayan Zhang et al.
PHARMACOLOGICAL RESEARCH (2019)
High-throughput metabolomics and ingenuity pathway approach reveals the pharmacological effect and targets of Ginsenoside Rg1 in Alzheimer's disease mice
Ge Li et al.
SCIENTIFIC REPORTS (2019)
Prospects for combining immune checkpoint blockade with PARP inhibition
Anping Li et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Studies of the effects and mechanisms of ginsenoside Re and Rk3 on myelosuppression induced by cyclophosphamide
Jiahong Han et al.
JOURNAL OF GINSENG RESEARCH (2019)
Cyclophosphamide Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression
Ali Roghanian et al.
CANCER IMMUNOLOGY RESEARCH (2019)
PARP Inhibitor Resistance: A Tug-of-War in BRCA-Mutated Cells
Sylvie M. Noordermeer et al.
TRENDS IN CELL BIOLOGY (2019)
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
T. A. Chan et al.
ANNALS OF ONCOLOGY (2019)
From Tumor Immunology to Immunotherapy in Gastric and Esophageal Cancer
David Vrana et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape
Xianjie Jiang et al.
MOLECULAR CANCER (2019)
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
Robert M. Samstein et al.
NATURE GENETICS (2019)
A Single-Cell Sequencing Guide for Immunologists (vol 9, 2425, 2018)
Peter See et al.
FRONTIERS IN IMMUNOLOGY (2019)
The complete plastid genome of Iris domestica: a traditional Chinese medicine
Hong-Lian Ai et al.
MITOCHONDRIAL DNA PART B-RESOURCES (2019)
Inhibition of the hypoxia-induced factor-1α and vascular endothelial growth factor expression through ginsenoside Rg3 in human gastric cancer cells
Bingqiang Li et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2019)
Ginsenoside Rg1 impairs homologous recombination repair by targeting CtBP-interacting protein and sensitizes hepatoblastoma cells to DNA damage
Ni Zhen et al.
ANTI-CANCER DRUGS (2018)
Metal Contents in the Most Widely Consumed Commercial Preparations of Four Different Medicinal Plants (Aloe, Senna, Ginseng, and Ginkgo) from Europe
Carmen Rubio et al.
BIOLOGICAL TRACE ELEMENT RESEARCH (2018)
Ginseng phytochemicals as therapeutics in oncology: Recent perspectives
Fatima Majeed et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Ginsenoside Rg3 Sensitizes Colorectal Cancer to Radiotherapy through Downregulation of Proliferative and Angiogenic Biomarkers
Taiguo Liu et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2018)
Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity
Qing Zhang et al.
NATURE IMMUNOLOGY (2018)
The reversal effect of Ginsenoside Rh2 on drug resistance in human colorectal carcinoma cells and its mechanism
Gui-wei Liu et al.
HUMAN CELL (2018)
Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations
Jun Gong et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
A Nobel Prize-worthy pursuit: cancer immunology and harnessing immunity to tumour neoantigens
Daniel M. Altmann
IMMUNOLOGY (2018)
Network Pharmacology to Unveil the Biological Basis of Health-Strengthening Herbal Medicine in Cancer Treatment
Jiahui Zheng et al.
CANCERS (2018)
Ginsenoside Rg3 Decreases NHE1 Expression via Inhibiting EGF-EGFR-ERK1/2-HIF-1α Pathway in Hepatocellular Carcinoma: A Novel Antitumor Mechanism
Xiao Li et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2018)
Shenmai injection enhances the cytotoxicity of chemotherapeutic drugs against colorectal cancers via improving their subcellular distribution
Wen-yue Liu et al.
ACTA PHARMACOLOGICA SINICA (2017)
LAG3 (CD223) as a cancer immunotherapy target
Lawrence P. Andrews et al.
IMMUNOLOGICAL REVIEWS (2017)
STAT3 Induces Immunosuppression by Upregulating PD-1/PD-L1 in HNSCC
L. L. Bu et al.
JOURNAL OF DENTAL RESEARCH (2017)
Ginsenoside Rg3 attenuates cisplatin resistance in lung cancer by downregulating PD-L1 and resuming immune
Zhansheng Jiang et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Programmed death-ligand 1 is prognostic factor in esophageal squamous cell carcinoma and is associated with epidermal growth factor receptor
Wencheng Zhang et al.
CANCER SCIENCE (2017)
Stephania Tetrandra and Ginseng-Containing Chinese Herbal Formulation NSENL Reverses Cisplatin Resistance in Lung Cancer Xenografts
Ling Jin et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2017)
Traditional Chinese medical comprehensive therapy for cancer-related fatigue
Yang Lu et al.
CHINESE JOURNAL OF INTEGRATIVE MEDICINE (2016)
Cancer Statistics, 2016
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Colorectal cancer statistics, 2014
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
Tumor-stroma ratio is an independent predictor for survival in early cervical carcinoma
Jing Liu et al.
GYNECOLOGIC ONCOLOGY (2014)
Stereospecific PARP Trapping by BMN 673 and Comparison with Olaparib and Rucaparib
Junko Murai et al.
MOLECULAR CANCER THERAPEUTICS (2014)
SICKLE-CELL DISEASE
Lauren Gravitz et al.
NATURE (2014)
Panax ginseng polysaccharide suppresses metastasis via modulating Twist expression in gastric cancer
Jian-Ping Cai et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2013)
Immunotherapy of cancer in 2012
John M. Kirkwood et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
Junko Murai et al.
CANCER RESEARCH (2012)
Full-length mRNA-Seq from single-cell levels of RNA and individual circulating tumor cells
Daniel Ramskold et al.
NATURE BIOTECHNOLOGY (2012)
Potentiation of etoposide-induced apoptosis in HeLa cells by co-treatment with KG-135, a quality-controlled standardized ginsenoside formulation
Won-Hee Lee et al.
CANCER LETTERS (2010)
Induction of tumoricidal activity in mouse peritoneal macrophages by ginseng polysaccharide
J. Wang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2010)
Over-expression of Na+/H+ exchanger 1 and its clinicopathologic significance in hepatocellular carcinoma
Xuekang Yang et al.
MEDICAL ONCOLOGY (2010)
Current Evaluation of the Millennium Phytomedicine-Ginseng (I): Etymology, Pharmacognosy, Phytochemistry, Market and Regulations
Lee Jia et al.
CURRENT MEDICINAL CHEMISTRY (2009)
mRNA-Seq whole-transcriptome analysis of a single cell
Fuchou Tang et al.
NATURE METHODS (2009)
Antiestrogenic effect of 20S-protopanaxadiol and its synergy with tamoxifen on breast cancer cells
Yan Yu et al.
CANCER (2007)
Panax ginseng - a non-organ-specific cancer preventive?
Taik-Koo Yun
LANCET ONCOLOGY (2001)
Share Paper
